Davis C. Ryman

1.1k total citations
7 papers, 113 citations indexed

About

Davis C. Ryman is a scholar working on Molecular Biology, Neurology and Genetics. According to data from OpenAlex, Davis C. Ryman has authored 7 papers receiving a total of 113 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 2 papers in Neurology and 2 papers in Genetics. Recurrent topics in Davis C. Ryman's work include Genetic Syndromes and Imprinting (2 papers), Parkinson's Disease Mechanisms and Treatments (2 papers) and Bioinformatics and Genomic Networks (2 papers). Davis C. Ryman is often cited by papers focused on Genetic Syndromes and Imprinting (2 papers), Parkinson's Disease Mechanisms and Treatments (2 papers) and Bioinformatics and Genomic Networks (2 papers). Davis C. Ryman collaborates with scholars based in United States, Canada and South Korea. Davis C. Ryman's co-authors include Bruce T. Lamb, Yuan Gao, Camila E. Orsso, Mark D. Inman, Andrea M. Haqq, Lisa C. Burnett, Qiming Tan, Kathryn J. Potter, Masahito Mihara and Susan Eaton and has published in prestigious journals such as Neurobiology of Aging, Alzheimer s & Dementia and Current Alzheimer Research.

In The Last Decade

Davis C. Ryman

7 papers receiving 109 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Davis C. Ryman United States	5	54	45	28	28	16	7	113
Juan Marín Spain	6	53 1.0×	72 1.6×	17 0.6×	21 0.8×	23 1.4×	11	117
Itziar de Rojas Spain	6	79 1.5×	61 1.4×	25 0.9×	19 0.7×	25 1.6×	21	169
Szi Kay Leung United Kingdom	5	199 3.7×	61 1.4×	29 1.0×	45 1.6×	19 1.2×	8	268
Oksana Shcherbakova United States	4	201 3.7×	83 1.8×	27 1.0×	34 1.2×	32 2.0×	5	260
Portia Chipendo United States	3	93 1.7×	104 2.3×	29 1.0×	29 1.0×	43 2.7×	3	194
Tara Skelly United States	7	123 2.3×	25 0.6×	14 0.5×	57 2.0×	31 1.9×	9	231
Amy He United States	4	100 1.9×	63 1.4×	21 0.8×	12 0.4×	34 2.1×	5	150
Mitja Kurki Finland	5	76 1.4×	85 1.9×	34 1.2×	30 1.1×	33 2.1×	6	165
Jillian Belgrad United States	6	102 1.9×	18 0.4×	31 1.1×	11 0.4×	41 2.6×	11	190
Janou A. Y. Roubroeks Netherlands	4	149 2.8×	47 1.0×	13 0.5×	47 1.7×	5 0.3×	5	187

Countries citing papers authored by Davis C. Ryman

Since Specialization

Citations

This map shows the geographic impact of Davis C. Ryman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Davis C. Ryman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Davis C. Ryman more than expected).

Fields of papers citing papers by Davis C. Ryman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Davis C. Ryman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Davis C. Ryman. The network helps show where Davis C. Ryman may publish in the future.

Co-authorship network of co-authors of Davis C. Ryman

This figure shows the co-authorship network connecting the top 25 collaborators of Davis C. Ryman. A scholar is included among the top collaborators of Davis C. Ryman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Davis C. Ryman. Davis C. Ryman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Ryman, Davis C. & Cheri Deal. (2021). Topline Results of the CARE-PWS Phase 3 Study: Intranasal Carbetocin Improves Hyperphagia and Anxiety and Distress Symptoms in Prader-Willi Syndrome (PWS). Journal of the Endocrine Society. 5(Supplement_1). A689–A689. 1 indexed citations

2.

Tan, Qiming, Kathryn J. Potter, Lisa C. Burnett, et al.. (2020). Prader–Willi-Like Phenotype Caused by an Atypical 15q11.2 Microdeletion. Genes. 11(2). 128–128. 30 indexed citations

3.

Budur, Kumar, Tim West, Joel B. Braunstein, et al.. (2017). [O2–17–01]: RESULTS OF A PHASE 1, SINGLE ASCENDING DOSE, PLACEBO‐CONTROLLED STUDY OF ABBV‐8E12 IN PATIENTS WITH PROGRESSIVE SUPRANUCLEAR PALSY AND PHASE 2 STUDY DESIGN IN EARLY ALZHEIMER's DISEASE. Alzheimer s & Dementia. 13(7S_Part_12). 9 indexed citations

4.

Murata, Miho, Masahito Mihara, Kazuko Hasegawa, et al.. (2016). Efficacy and safety of levodopa–carbidopa intestinal gel from a study in Japanese, Taiwanese, and Korean advanced Parkinson’s disease patients. npj Parkinson s Disease. 2(1). 16020–16020. 13 indexed citations

5.

Ryman, Davis C., et al.. (2014). O3‐06‐01: PREDICTING SYMPTOM ONSET IN AUTOSOMAL DOMINANT ALZHEIMER'S DISEASE: A SYSTEMATIC REVIEW AND META‐ANALYSIS. Alzheimer s & Dementia. 10(4S_Part_3). 2 indexed citations

6.

Ryman, Davis C., Yuan Gao, & Bruce T. Lamb. (2007). Genetic loci modulating amyloid-beta levels in a mouse model of Alzheimer's disease. Neurobiology of Aging. 29(8). 1190–1198. 28 indexed citations

7.

Ryman, Davis C. & Bruce T. Lamb. (2006). Genetic and Environmental Modifiers of Alzheimers Disease Phenotypes in the Mouse. Current Alzheimer Research. 3(5). 465–473. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact